Cargando…

Loss of heterozygosity of TRIM3 in malignant gliomas

BACKGROUND: Malignant gliomas are frequent primary brain tumors associated with poor prognosis and very limited response to conventional chemo- and radio-therapies. Besides sharing common growth features with other types of solid tumors, gliomas are highly invasive into adjacent brain tissue, which...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boulay, Jean-Louis, Stiefel, Urs, Taylor, Elisabeth, Dolder, Béatrice, Merlo, Adrian, Hirth, Frank
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653542/ https://www.ncbi.nlm.nih.gov/pubmed/19250537 http://dx.doi.org/10.1186/1471-2407-9-71

Ejemplares similares

Loss of heterozygosity (LOH), malignancy grade and clonality in microdissected prostate cancer
por: Hügel, A, et al.
Publicado: (1999)

Loss of heterozygosity: what is it good for?
por: Ryland, Georgina L., et al.
Publicado: (2015)

A new method to detect loss of heterozygosity using cohort heterozygosity comparisons
por: Green, Michael R, et al.
Publicado: (2010)

Loss of Heterozygosity and Its Importance in Evolution
por: Smukowski Heil, Caiti
Publicado: (2023)

Genome-scale patterns in the loss of heterozygosity incidence in Saccharomyces cerevisiae
por: Tutaj, Hanna, et al.
Publicado: (2022)

Genomic loss of heterozygosity and survival in the REAL3 trial
por: Smyth, Elizabeth C., et al.
Publicado: (2018)

Analysis of Loss of Heterozygosity in Korean Patients with Keratoacanthoma
por: Ha, Tae-Won, et al.
Publicado: (2005)

Loss of Heterozygosity Drives Adaptation in Hybrid Yeast
por: Smukowski Heil, Caiti S., et al.
Publicado: (2017)

Targeting tumor vulnerabilities associated with loss of heterozygosity
por: Rendo, Veronica, et al.
Publicado: (2020)

Fitness benefits of loss of heterozygosity in Saccharomyces hybrids
por: Lancaster, Samuel M., et al.
Publicado: (2019)

Targeting loss of heterozygosity for cancer-specific immunotherapy
por: Hwang, Michael S., et al.
Publicado: (2021)

Polyploidy as an Adaptation against Loss of Heterozygosity in Cancer
por: Archetti, Marco
Publicado: (2022)

Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma
por: Pastorino, Lorenza, et al.
Publicado: (2022)

Exploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy
por: Rendo, Veronica, et al.
Publicado: (2020)

Loss of heterozygosity and SOSTDC1 in adult and pediatric renal tumors
por: Blish, Kimberly R, et al.
Publicado: (2010)

Proteome-based insights for IDH-mutant glioma classification
por: Leu, Severina, et al.
Publicado: (2023)

Notch signaling in glioblastoma: a developmental drug target?
por: Lino, Maria Maddalena, et al.
Publicado: (2010)

Copy-neutral loss of heterozygosity and chromosome gains and losses are frequent in gastrointestinal stromal tumors
por: Lourenço, Nelson, et al.
Publicado: (2014)

Loss of heterozygosity at 7p in Wilms' tumour development
por: Powlesland, R M, et al.
Publicado: (2000)

Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan
por: Sheu, J-C, et al.
Publicado: (1999)

Loss of constitutional heterozygosity on chromosomes 5 and 17 in cholangiocarcinoma.
por: Ding, S. F., et al.
Publicado: (1993)

Loss of heterozygosity on chromosomes 1 and 11 in carcinoma of the pancreas.
por: Ding, S. F., et al.
Publicado: (1992)

Loss of heterozygosity of the oestrogen receptor gene in breast cancer.
por: Iwase, H., et al.
Publicado: (1995)

Loss of heterozygosity on chromosome 16 in sporadic Wilms' tumour.
por: Grundy, R. G., et al.
Publicado: (1998)

Clinical Implications of Genomic Loss of Heterozygosity in Endometrial Carcinoma
por: Bustamante, Bethany, et al.
Publicado: (2021)

Value of the loss of heterozygosity to BRCA1 variant classification
por: Santana dos Santos, Elizabeth, et al.
Publicado: (2022)

Loss of heterozygosity on chromosome 10, 13q(Rb), 17p, and p53 gene mutations in human brain gliomas.
por: Lee, S. H., et al.
Publicado: (1995)

NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation
por: Brosseau, Jean-Philippe, et al.
Publicado: (2018)

Loss of heterozygosity on the long arm of chromosome 11 in colorectal tumours.
por: Gustafson, C. E., et al.
Publicado: (1994)

Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma.
por: Foulkes, W. D., et al.
Publicado: (1993)

Sequential loss of heterozygosity in the progression of squamous cell carcinoma of the lung.
por: Endo, C., et al.
Publicado: (1998)

Stress Alters Rates and Types of Loss of Heterozygosity in Candida albicans
por: Forche, A., et al.
Publicado: (2011)

Loss of Heterozygosity Drives Clonal Diversity of Phytophthora capsici in China
por: Hu, Jian, et al.
Publicado: (2013)

Association of Loss of Heterozygosity at the p53 Locus with Chemoresistance in Osteosarcomas
por: Goto, Akiteru, et al.
Publicado: (1998)

Targeting Loss of Heterozygosity: A Novel Paradigm for Cancer Therapy
por: Zhang, Xiaonan, et al.
Publicado: (2021)

Overdominant Mutations Restrict Adaptive Loss of Heterozygosity at Linked Loci
por: Fisher, Kaitlin J, et al.
Publicado: (2021)

Drivers of genomic loss of heterozygosity in leiomyosarcoma are distinct from carcinomas
por: Seligson, Nathan D., et al.
Publicado: (2022)

Genome plasticity driven by aneuploidy and loss of heterozygosity in Trypanosoma cruzi
por: Cruz-Saavedra, Lissa, et al.
Publicado: (2022)

PB1836: LOSS OF HETEROZYGOSITY IN AML PATIENTS WITH INV(16)
por: Bessmertniy, Dmitry, et al.
Publicado: (2023)

TRIM28 is overexpressed in glioma and associated with tumor progression
por: Su, Chunhai, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mcrn6dn8gh2f9meg9o1ilvtpin